Teaching the Immune System to Let Medicines Do Their Job

RARECast - A podcast by RARECast - Thursdays

Categories:

Carsten Brunn, president and CEO of Selecta Biosciences, discusses the problem of immunogenicity to biologics, the company’s ImmTOR platform, and how its leveraging that platform with a growing pipeline of biologics and gene therapies.